Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Freemantle

Showing results (251-260 of 300) with videos related to

Pageof 30
Sort By:
Bjpsych Open|September 17, 2020
Prevalence of treatment resistance and clozapine use in early intervention servicesImogen Stokes, Siân Lowri Griffiths, Rowena Jones, et al.
Schizophrenia Research|August 10, 2014
Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort studyMax Marshall, Nusrat Husain, Natalie Bork, et al.
Therapeutic Advances in Medical Oncology|June 24, 2022
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50Nick Freemantle, Yingxin Xu, Florence R Wilson, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 1, 2024
Early neurological deterioration in acute lacunar ischemic stroke: Systematic review of incidence, mechanisms, and prospects for treatmentDavid J Werring, Hatice Ozkan, Fergus Doubal, et al.
Applied Health Economics and Health Policy|November 8, 2021
Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER StudyCaroline S Clarke, Larisa Duffy, Glyn Lewis, et al.
Trials|March 9, 2021
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trialLi-An K Brown, Nick Freemantle, Judy Breuer, et al.
Frontiers in Oncology|April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancerJosephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
European Journal of Heart Failure|January 16, 2007
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or dischargeNasrin K Khan, Kevin M Goode, John G F Cleland, et al.
Social Psychiatry and Psychiatric Epidemiology|January 30, 2023
Five-year illness trajectories across racial groups in the UK following a first episode psychosisSiân Lowri Griffiths, Tumelo Bogatsu, Mia Longhi, et al.
Nature Communications|March 16, 2025
High-dose vitamin D<sub>3</sub> to improve outcomes in the convalescent phase of complicated severe acute malnutrition in Pakistan: a double-blind randomised controlled trial (ViDiSAM)Javeria Saleem, Rubeena Zakar, Muhammad Salman Butt, et al.
Pageof 30

Showing results (251-260 of 300) with videos related to

Sort By:
Pageof 30
Bjpsych Open|September 17, 2020
Prevalence of treatment resistance and clozapine use in early intervention servicesImogen Stokes, Siân Lowri Griffiths, Rowena Jones, et al.
Schizophrenia Research|August 10, 2014
Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort studyMax Marshall, Nusrat Husain, Natalie Bork, et al.
Therapeutic Advances in Medical Oncology|June 24, 2022
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50Nick Freemantle, Yingxin Xu, Florence R Wilson, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 1, 2024
Early neurological deterioration in acute lacunar ischemic stroke: Systematic review of incidence, mechanisms, and prospects for treatmentDavid J Werring, Hatice Ozkan, Fergus Doubal, et al.
Applied Health Economics and Health Policy|November 8, 2021
Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER StudyCaroline S Clarke, Larisa Duffy, Glyn Lewis, et al.
Trials|March 9, 2021
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trialLi-An K Brown, Nick Freemantle, Judy Breuer, et al.
Frontiers in Oncology|April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancerJosephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
European Journal of Heart Failure|January 16, 2007
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or dischargeNasrin K Khan, Kevin M Goode, John G F Cleland, et al.
Social Psychiatry and Psychiatric Epidemiology|January 30, 2023
Five-year illness trajectories across racial groups in the UK following a first episode psychosisSiân Lowri Griffiths, Tumelo Bogatsu, Mia Longhi, et al.
Nature Communications|March 16, 2025
High-dose vitamin D<sub>3</sub> to improve outcomes in the convalescent phase of complicated severe acute malnutrition in Pakistan: a double-blind randomised controlled trial (ViDiSAM)Javeria Saleem, Rubeena Zakar, Muhammad Salman Butt, et al.
Pageof 30